Company Filing History:
Years Active: 2009-2012
Title: Hilmar Ilgenfritz: Innovator in Lipolytic Enzymes
Introduction
Hilmar Ilgenfritz is a notable inventor based in Martinsried, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of novel lipolytic enzymes. With a total of 2 patents to his name, his work has implications for both industrial processes and medical diagnostics.
Latest Patents
Ilgenfritz's latest patents focus on a newly identified polynucleotide sequence that encodes a novel lipolytic enzyme. The invention includes the full-length nucleotide sequence of the gene, the cDNA sequence that comprises the full-length coding sequence, and the amino acid sequence of the functional protein. Additionally, the patents describe methods for utilizing these enzymes in industrial applications and for diagnosing fungal infections. The invention also encompasses genetically modified cells that enhance the activity and expression levels of the lipolytic enzyme.
Career Highlights
Hilmar Ilgenfritz is currently associated with DSM IP Assets B.V., where he continues to innovate in the field of enzyme technology. His work has been instrumental in advancing the understanding and application of lipolytic enzymes in various sectors.
Collaborations
Ilgenfritz collaborates with notable colleagues such as Richard Albang and Andreas Fritz, contributing to a dynamic research environment that fosters innovation.
Conclusion
Hilmar Ilgenfritz stands out as a key figure in the development of lipolytic enzymes, with his patents paving the way for advancements in both industrial and medical fields. His contributions continue to impact the biotechnology landscape significantly.